Provided by Tiger Trade Technology Pte. Ltd.

HANSOH PHARMA

37.120
+0.6401.75%
Volume:10.16M
Turnover:375.84M
Market Cap:224.76B
PE:44.56
High:37.400
Open:36.900
Low:36.580
Close:36.480
52wk High:44.220
52wk Low:16.911
Shares:6.06B
HK Float Shares:6.06B
Volume Ratio:1.20
T/O Rate:0.17%
Dividend:0.37
Dividend Rate:0.99%
EPS(LYR):0.833
ROE:16.21%
ROA:8.35%
PB:6.40
PE(LYR):44.56
PS:15.08

Loading ...

Hansoh Pharmaceutical Group Stock Rises 1.8% in Hong Kong

Dow Jones
·
Yesterday

Goldman Sachs: Mainland Healthcare Sector Returns to Hinge on Data and Earnings Visibility This Year, CDMO Firms Favored

Stock News
·
Yesterday

Hansoh Pharmaceutical Group Stock Slips 1.5% in Hong Kong

Dow Jones
·
Feb 04

Hansoh Pharmaceutical (3692) Completes HK$4,680 Million Zero Coupon Convertible Bond Issue

Bulletin Express
·
Feb 03

Hansoh Pharmaceutical Completes HK$4.68 Billion Zero Coupon Convertible Bond Issue

Reuters
·
Feb 03

Hansoh Pharmaceutical (03692) Announces January 2026 Monthly Return and Convertible Bonds Maturity

Bulletin Express
·
Feb 03

Hansoh Pharmaceutical Group Stock Falls 3.2% in Hong Kong

Dow Jones
·
Feb 02

Hansoh Pharmaceutical Group Stock Falls 1.4% in Hong Kong

Dow Jones
·
Jan 29

Hansoh Pharmaceutical Group Stock Slips 4.4% in Hong Kong

Dow Jones
·
Jan 27

BRIEF-Hansoh Pharmaceutical Issue Of Hk$4,680 Million Zero Coupon Convertible Bonds Due 2033

Reuters
·
Jan 27

HANSOH PHARMA (03692) Proposes Issuance of HK$4.68 Billion Zero-Coupon Convertible Bonds Due 2033

Stock News
·
Jan 27

Hansoh Pharmaceutical - Proposed Issue of HK$4,680 Mln Zero Coupon Convertible Bonds Due 2033

THOMSON REUTERS
·
Jan 27

Does Hansoh Pharmaceutical Group's (SEHK:3692) Ameile Label Expansion Reveal a Deeper Oncology Strategy Shift?

Simply Wall St.
·
Jan 22

Hansoh Pharmaceutical Group Stock Sheds 4.0% in Hong Kong

Dow Jones
·
Jan 19

Hansoh Pharmaceutical Group Stock Rallies 2.1% in Hong Kong

Dow Jones
·
Jan 14

HK Stock Movement | HANSOH PHARMA (03692) Rises Over 4% Before Noon; Ameile® Gains Fifth Indication Approval; Adjuvant Therapy Research Published in The Lancet Oncology

Stock News
·
Jan 13

China Approves Ameile Combination Therapy as First-Line Treatment for EGFR-Mutated NSCLC

Reuters
·
Jan 12

Hansoh Pharmaceutical Group Stock Sheds 2.3% in Hong Kong

Dow Jones
·
Jan 12

Hansoh Pharmaceutical Group SEHK 3692 Valuation Check After Ameile First Line Lung Cancer Approval

Simply Wall St.
·
Jan 10

Hansoh Pharma Gets China Nod for Additional Indication of Lung Cancer Drug

MT Newswires Live
·
Jan 08